Company intelligence / Profile preview

Verus Pharma B.V.

Amsterdam*, Netherlandsverus-pharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Verus Pharma B.V. is an active pharmaceutical company based in the Netherlands, focused on providing innovative treatments and solutions for rare diseases and oncology. The company acts as a partner to multinational firms—especially those working in gene therapy—and provides distribution, import/export services, medical marketing support, and clinical research project facilitation across Europe and globally. It is known for its ethical approach and strong business partnerships but does not appear to develop proprietary drugs itself.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Gene therapiesSmall molecules (inferred from rare disease/oncology focus)Other modalities possible but not explicitly listed
Industry: Drug Discovery Services

Partnerships

Matrix Biotechnology Co. distributorship for BENELUX region announced April 2024

Beyond the preview

Go deeper on Verus Pharma B.V..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verus Pharma B.V..

Explore the full profile